Context Therapeutics Ratios (2020-2026) | CNTX

Ratios Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Efficiency
Assets Average (Quarter)
26.78M49.17M45.86M43.39M40.02M34.97M29.86M25.38M19.53M13.56M56.88M94.52M92.23M95.55M90.06M83.19M73.86M63.68M
Equity Average (Quarter)
-19.89M-22.76M12.53M46.83M43.52M39.86M36.41M31.75M26.37M21.19M15.13M10.16M54.77M92.48M89.56M93.12M86.76M77.86M66.82M56.34M
Invested Capital (Quarter)
-22.30M-23.21M48.27M45.39M41.65M38.07M34.76M28.73M24.00M18.38M11.87M8.44M101.10M83.86M95.27M90.98M82.54M73.17M60.47M52.20M
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-0.00M0.01M
Debt to Equity (Quarter)
Debt Ratio (Quarter)
Equity Ratio (Quarter)
-10.270.940.970.930.900.920.900.860.800.740.760.980.970.970.980.950.920.880.89
Times Interest Earned (Quarter)
-0.00M0.01M
Valuation
Enterprise Value (Quarter)
-0.42M-49.69M-45.70M-42.92M-39.40M-35.50M-29.80M-25.14M-21.68M-14.45M-10.10M-101.54M-84.80M-94.43M-89.35M-83.52M-76.90M-66.00M-54.53M
Return Ratios
Return on Capital Employed (Quarter)
-44.32%-27.60%-28.28%-37.05%-41.78%-58.63%-76.18%-106.02%-163.51%-203.03%-36.23%-35.30%-33.44%-33.78%-44.79%-39.15%-60.30%-76.16%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.02%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%
Return on Equity (Quarter)
0.00%0.00%-0.01%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.02%-0.02%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%